Nearly 40 years after he began using smokeless tobacco, Tuttle developed a tumor in his mouth so severe, it protruded through his skin
For example, if CMS grants a severe supply chain disruption rebate reduction request for a generic Part D rebatable drug or biosimilar that was submitted on November 15, 2024, and that generic Part D rebatable drug or biosimilar is currently in shortage from September 15, 2025, until May 15, 2026, CMS would apply a 75 percent reduction in the total rebate amount for the duration of the applicable period for which the severe supply chain disruption rebate reduction request was granted (that is, October 1, 2024, to September 30, 2025), and then would apply the shortages reduction as proposed in 428.301, beginning with a reduction of 25 percent for a biosimilar or 75 percent for a generic Part D rebatable drug or plasma-derived product that is a biosimilar for the applicable period beginning October 1, 2025
It's still an extremely deadly disease. In part, this is because of the lower lung scrutiny that never-smokers get
Instead, smokers looking for alternatives gravitated toward heated tobacco products
